How Much Did Avid Bioservices Raise?
Funding & Key Investors

Avid Bioservices has solidified its position within the competitive biologics landscape, securing a total capital infusion of $1.5M. This recent strategic investment of $1.5M underscores the firm's commitment to expanding its enterprise-level manufacturing capabilities. As a critical player in the pharmaceutical supply chain, the organization continues to leverage this financial backing to enhance its infrastructure and service offerings for global biotechnology partners.

What is Avid Bioservices?

Avid Bioservices
ManufacturingPharmaceuticalsBusiness Services

Avid Bioservices operates as a specialized contract development and manufacturing organization (CDMO) headquartered in the United States. The company provides a comprehensive suite of integrated services, ranging from early-stage cell line development to full-scale commercial production. By maintaining rigorous CGMP standards, Avid Bioservices supports the complex requirements of pharmaceutical innovators, focusing specifically on mammalian cell culture, analytical development, and formulation. Their market position is defined by an ability to facilitate seamless technology transfers, ensuring that client programs move efficiently from clinical trials to market-ready commercialization.

How much funding has Avid Bioservices raised?

Avid Bioservices has raised a total of $1.5M across 1 funding round:

2003

Debt

$1.5M

Debt (2003): $1.5M, investors not publicly disclosed

Key Investors in Avid Bioservices

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Avid Bioservices?

With the recent influx of capital, Avid Bioservices is well-positioned to scale its operational footprint and address the growing demand for high-quality biologics manufacturing. The strategic focus will likely center on increasing capacity for mammalian cell culture and optimizing analytical development workflows to reduce time-to-market for client pipelines. As the pharmaceutical industry continues to prioritize outsourcing for complex biologics, Avid Bioservices is poised to capture additional market share by enhancing its technical capabilities and reinforcing its reputation as a reliable partner for clinical and commercial-scale production. Future growth will be driven by the integration of advanced manufacturing technologies and the expansion of its service portfolio to meet evolving regulatory and technical standards.

See full Avid Bioservices company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Cleaning ProductsManufacturing
Food & BeverageManufacturingRetailGrocery Retail
ManufacturingPlastic, Packaging & Containers
Building MaterialsManufacturingBusiness ServicesCommercial Printing

Frequently Asked Questions Regarding Avid Bioservices Financial Insights

What are the most recent funding rounds that Avid Bioservices has completed, and what were the funding rounds?
Avid Bioservices has recently completed 1 funding rounds: Debt on Jun 8, 2003.
What is the total amount of funding Avid Bioservices has raised to date?
Avid Bioservices has raised a total of $1.5M in funding to date.
How many funding rounds has Avid Bioservices completed?
Avid Bioservices has completed 1 funding rounds.
How much funding did Avid Bioservices raise in its most recent funding round?
Avid Bioservices raised $1.5M in its most recent funding round.
Which was the largest funding round in Avid Bioservices's history?
The largest funding round in Avid Bioservices's history was $1.5M.
See more information about Avid Bioservices